
Endogenous C-type natriuretic peptide (CNP) / NPR-B signaling as a super-slow paracrine set-point modulator of the sino-atrial node, and a stabilized CNP analog peptide (VLADOS-2) to durably lower resting heart rate without the negative inotropy of beta-blockade. Field: cardiovascular peptide pharmacology / autonomic regulation.
Owner